Atlas Trials

Study Evaluating Antibiotic Use in Reducing Vancomycin-Resistant Enterococci and ESBL Producing Escherichia Coli and Klebsiella Pneumoniae in Intensive Care

Clinical trial NCT00167986 · COMPLETED

Trial details

NCT number
NCT00167986
Sponsor
Wyeth is now a wholly owned subsidiary of Pfizer
Status
COMPLETED
Study type
OBSERVATIONAL
Escherichia Coli InfectionsKlebsiella Infections
Start date
2005-01-01
Enrollment
480

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.